Cystatin D Fibrinogen Like Protein 1
NCT05929989 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2023-07-05
Summary
to detect role of cystatin D and fibrinogen like protein 1 in rheumatoid arthritis asses relationship between disease activity and cystatin D and fibrinogen like protein 1
Conditions
- Fibrinogen Like Protein 1
Interventions
- DIAGNOSTIC_TEST
-
ELISA TEST
ELISA TEST for cystatin D and fibrinogen like protein
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
More Related Trials
-
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
NCT01111357 ·Status: COMPLETED
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
NCT02927509 ·Status: COMPLETED
-
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
NCT01211678 ·Status: COMPLETED
-
Biomarkers in Chronic Arthritis
NCT02909998 ·Status: COMPLETED
-
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00256919 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
NCT04343378 ·Status: COMPLETED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis
NCT05119452 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
NCT00751387 ·Status: COMPLETED
-
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
NCT03492658 ·Status: COMPLETED ·Phase: PHASE4
-
Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents
NCT01691014 ·Status: TERMINATED
-
Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
NCT01961310 ·Status: COMPLETED
-
Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
NCT04655612 ·Status: COMPLETED
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes
NCT00845949 ·Status: WITHDRAWN
-
Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice
NCT01692899 ·Status: COMPLETED
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years
NCT02894047 ·Status: COMPLETED
-
Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
NCT05422313 ·Status: UNKNOWN
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED